JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

CHANGE OF VENUE OF ANNUAL GENERAL MEETING AND H SHARE CLASS MEETING TO BE HELD ON FRIDAY, 9 JUNE 2023

CHANGE OF VENUE OF ANNUAL GENERAL MEETING AND H SHARE CLASS MEETING TO BE HELD ON FRIDAY, 9 JUNE 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2023

Final dividend in bonus shares for the year ended December 31, 2022

Final dividend in bonus shares for the year ended December 31, 2022

Final dividend in cash for the year ended December 31, 2022

Final dividend in cash for the year ended December 31, 2022

Form of Proxy for the First H Share Class Meeting of 2023

Form of Proxy for the First H Share Class Meeting of 2023

NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2023

NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2023

Form of Proxy for the Annual General Meeting

Form of Proxy for the Annual General Meeting

NOTICE OF THE ANNUAL GENERAL MEETING OF 2022

NOTICE OF THE ANNUAL GENERAL MEETING OF 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2023

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top